PE20090249A1 - Composicion farmaceutica para el tratamiento de endometriosis - Google Patents

Composicion farmaceutica para el tratamiento de endometriosis

Info

Publication number
PE20090249A1
PE20090249A1 PE2008000827A PE2008000827A PE20090249A1 PE 20090249 A1 PE20090249 A1 PE 20090249A1 PE 2008000827 A PE2008000827 A PE 2008000827A PE 2008000827 A PE2008000827 A PE 2008000827A PE 20090249 A1 PE20090249 A1 PE 20090249A1
Authority
PE
Peru
Prior art keywords
pharmaceutical composition
endometriosis
treatment
refers
lipoid
Prior art date
Application number
PE2008000827A
Other languages
English (en)
Inventor
Daniel J Thompson
Robert C Cuca
Riley
Jonathan Bortz
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of PE20090249A1 publication Critical patent/PE20090249A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE; ENTRE 3 A 30% DE DANAZOL Y UNA FASE INTERNA Y FASE EXTERNA EN PROPORCION DE 50:50 A 85:15 EN PESO, EN EL QUE: LA FASE INTERNA NO LIPOIDEA CONTIENE POR LO MENOS UN POLIOL, TAL COMO GLICEROL, SORBITOL, ENTRE OTROS; Y LA FASE EXTERNA LIPOIDEA CONTIENE AL MENOS UN ACEITE MINERAL O VEGETAL; UN EMULSIFICANTE, TAL COMO MONOISOESTEARATO DE GLICERILO, POLIGLICERIL-3-TRIOLEATO, ENTRE OTROS; Y UN AGENTE MODULADOR DE VISCOSIDAD, TAL COMO CERA MICROCRISTALINA Y/O SILICE HIDROFOBO. SE REFIERE TAMBIEN A UN PROCESO DE PREPARACION. DICHA COMPOSICION TIENE LA FORMA FARMACEUTICA DE CREMA VAGINAL O SUPOSITORIO
PE2008000827A 2007-05-14 2008-05-12 Composicion farmaceutica para el tratamiento de endometriosis PE20090249A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91774807P 2007-05-14 2007-05-14

Publications (1)

Publication Number Publication Date
PE20090249A1 true PE20090249A1 (es) 2009-04-08

Family

ID=40028119

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000827A PE20090249A1 (es) 2007-05-14 2008-05-12 Composicion farmaceutica para el tratamiento de endometriosis

Country Status (5)

Country Link
US (2) US20080287408A1 (es)
AR (1) AR066324A1 (es)
CL (1) CL2008001411A1 (es)
PE (1) PE20090249A1 (es)
WO (1) WO2008144143A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784578A (zh) * 2015-05-11 2015-07-22 李汶峰 一种治疗盆腔炎的中药
EP3641821A2 (en) * 2017-06-22 2020-04-29 Viramal Limited Compositions for drug delivery and methods of use thereof
CN107468865A (zh) * 2017-09-06 2017-12-15 翔宇药业股份有限公司 蒲苓盆炎康颗粒的制备工艺

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551148A (en) * 1982-09-07 1985-11-05 Kv Pharmaceutical Company Vaginal delivery systems and their methods of preparation and use
US4837212A (en) * 1984-11-15 1989-06-06 University Of Miami Treatment of hemolytic anemia with danazol
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
JP2590358B2 (ja) * 1988-03-01 1997-03-12 正雄 五十嵐 子宮内膜症治療用の子宮内又は膣内投与製剤
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5514698A (en) * 1994-03-21 1996-05-07 Ortho Pharmaceutical Corporation Antifungal vaginal cream composition
US20030216335A1 (en) * 2001-11-30 2003-11-20 Jennifer Lockridge Method and reagent for the modulation of female reproductive diseases and conditions
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US5942539A (en) * 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
US6207696B1 (en) * 1998-09-15 2001-03-27 Cytos Pharamaceuticals, Llc Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
DE60218375D1 (de) * 2001-03-30 2007-04-12 Chisso Corp Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
US20050197651A1 (en) * 2001-04-25 2005-09-08 Chen Hai L. Vaginal ring preparation and its application
CA2456977C (en) * 2001-08-16 2011-06-07 The Trustees Of The University Of Pennsylvania Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
US20040152639A1 (en) * 2001-08-28 2004-08-05 Siler-Khodr Theresa M. Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
US20040223971A1 (en) * 2003-04-07 2004-11-11 Glycogenesys, Inc. Composition and uses of galectin antagonists
JP2004323454A (ja) * 2003-04-25 2004-11-18 Chisso Corp 薬剤
DE602004002591T9 (de) * 2003-05-22 2008-01-03 Pantarhei Bioscience B.V. Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
GB0320238D0 (en) * 2003-08-29 2003-10-01 Medical Res Council Treatment of disease
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
WO2005027807A1 (en) * 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
US7531542B2 (en) * 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US20060100154A1 (en) * 2005-10-13 2006-05-11 Yeda Research And Development Co Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
EA200870155A1 (ru) * 2006-01-05 2009-02-27 Драгтек Корпорейшн Система доставки лекарственного средства

Also Published As

Publication number Publication date
US20130184245A1 (en) 2013-07-18
WO2008144143A1 (en) 2008-11-27
CL2008001411A1 (es) 2008-12-19
US20080287408A1 (en) 2008-11-20
AR066324A1 (es) 2009-08-12

Similar Documents

Publication Publication Date Title
HRP20171691T1 (hr) Umjetne suze i njihova upotreba u terapiji
MX2015000554A (es) Encapsulación de fases inmisibles en biomateriales de fibroína de seda.
BR112012006665A2 (pt) composição, e, método compreendendo aplicar a composição
WO2014023640A3 (en) Cosmetic compositions
BR112014000382A2 (pt) uso de microemulsões em composições cosméticas de limpeza
PE20081684A1 (es) Microcapsulas vegetarianas
MX2010009460A (es) Confiteria de regiones multiples.
CL2019000607A1 (es) Composición para aplicación tópica con actividad antifúngica.
BR112014031914A2 (pt) cápsula de estradiol solúvel para inserção vaginal
CL2011000214A1 (es) Composicion farmaceutica que comprende progesterona micronizada y aceite de cartamo tipo ii; y uso para el tratamiento de una condicion relacionada con la insuficiencia de secrecion de progesterona.
BR112015020049A2 (pt) composição na forma de uma emulsão óleo-em-água e processo cosmético
CO6220842A2 (es) Composiciones antitranspirantes/desodorantes
CL2012000246A1 (es) Composicion que comprende al menos un sulfuro organico, opcionalmente en forma de oxido y al menos un agente que enmascara el olor, que comprende al menos un monoester, al menos un di-y/o triester, al menos un alcohol, al menos una cetona y opcionalmente al menos un terpeno.
CL2011001875A1 (es) Preparación farmaceutica semisólida transdérmica que contiene partículas de al menos un ingrediente activo recubierto con un aceite de silicona volátil o una mezcla de estos aceites,dispersos en un vehículo de base de gel o crema;método para su elaboración.
AR069317A1 (es) Composicion topica para controlar el sudor
PE20090249A1 (es) Composicion farmaceutica para el tratamiento de endometriosis
PE20061365A1 (es) Composiciones farmaceuticas de liberacion modificada
BR112013020783A2 (pt) tela, método para expandir uma tela e método para conformar uma tela a um furo de poço
AR066831A1 (es) Soles a base de silice
CL2008003002A1 (es) Composición farmacéutica inyectable intravenosa en forma de emulsión aceite en agua que comprende al toxoide larotaxel (xrp9881) o cabazitaxel (xrp6258) disuelto en lecitina, y al tensioactivo aniónico fosfatidilglicerol o acido fosfatidico; proeceidimiento para su preparacion, útil como antineoplástico.
BR112016021994A2 (pt) Formulação para a higiene pessoal
NI201400096A (es) Composiciones de liberación controlada y métodos para su uso
CO6771424A2 (es) Emulsión de aceite en agua o de agua en aceite basada en aceites vegetales como adyuvante fitofarmacéutico
EA201070257A1 (ru) Ароматизированная терапевтическая композиция на основе глины
AR088905A1 (es) Composiciones antitranspirantes solidas blandas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal